Actively Recruiting
Metabolomic Profiling of Patients With Traumatic Brain Injury
Led by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Updated on 2025-12-18
60
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.
CONDITIONS
Official Title
Metabolomic Profiling of Patients With Traumatic Brain Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18-65
- Patients diagnosed with severe TBI clinically or by National Institute for Health and Care Excellence (NICE) criteria, including post-traumatic imaging
- Patients with non-TBI orthopedic or multitrauma
You will not qualify if you...
- Presence of brain pathology before the trauma
- Patients with chronic subdural hematoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aksaray University
Aksaray, Ankara, Turkey (Türkiye), 06810
Actively Recruiting
Research Team
H
Hazal Ekin AYTUĞ, Consultant anesthesiologist
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here